The US food and drug administration's efforts to support ophthalmology clinical trials

JAMA Ophthalmology

Volumn 132, Issue 12, 2014, Pages 1391-1392

  Eydelman, Malvina B ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAILY LIFE ACTIVITY; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; HEALTH CARE COST; HUMAN; LENS IMPLANT; NOTE; OPHTHALMOLOGICAL EQUIPMENT; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; VISION; VISUAL PROSTHESIS; CLINICAL TRIAL (TOPIC); LEGISLATION AND JURISPRUDENCE; UNITED STATES;

CLINICAL TRIALS AS TOPIC; HUMANS; OPHTHALMOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84918518011     PISSN: 21686165     EISSN: 21686173     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.2826     Document Type: Note

References (7)

1. US Food and Drug Administration. Center for Devices and Radiological Health 2014-2015 strategic priorities. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHVisionandMission/ucm384132.htm. Accessed June 1, 2014
2. Weinreb RN, Kaufman PL. Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: Measures of structural change and visual function. Invest Ophthalmol Vis Sci. 2011;52 (11):7842-7851
3. Varma R, Richman EA, Ferris FL III, Bressler NM. Use of patient-reported outcomes in medical product development: A report from the 2009 NEI/FDA Clinical Trial Endpoints Symposium. Invest Ophthalmol Vis Sci. 2010;51(12):6095-6103
4. US Food and Drug Administration. Guidance for industry and FDA staff: Investigational device exemption (IDE) guidance for retinal prostheses. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm341954.htm. Accessed May 15, 2014
5. US Food and Drug Administration. Public Workshop: FDA/American Glaucoma Society Workshop on the Validity, Reliability, and Usability of Glaucoma Imaging Devices, October 5, 2012. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm318305.htm. Accessed May 20, 2014
6. American Academy of Ophthalmology. Agenda for Developing Novel Endpoints for Premium Intraocular Lenses (IOL)Workshop. http://www.aao.org/meetings/upload/FDA-iol-workshop-agenda.pdf. Accessed June 1, 2014
7. American Academy of Ophthalmology. Breakout session discussion questions for the participants. http://www.aao.org/meetings/upload/Breakout-Session-Discussion-Questions-for-the-Participants.pdf. Accessed June 1, 2014.